Brochure
12 Sep 2024
[Plasma derivatives] I.V.-Globulin SN inj
PDF 383 kB
▪Solvent/Detergent treated and Nanofiltered ▪For intravenous use only ▪Plasma from healthy donors
✔ Alyglo : Human Intravenous immunoglobulin 10%
- U.S. Approval in 2023
- Successfully launching in 2024
✔ I.V.-Globulin SN inj. : Human intravenous Immunoglobulin 5%, 10%
- A dominant leader of Korea since 1970
- 611 mil. liters of IVIG distributed worldwide
Content provided by our supplier
GC Biopharma
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:3
-
Employees:5000+
Company types
Primary activities
Other Content from GC Biopharma (18)
-
![[Plasma derivatives] Albumin inj.](https://www.cphi-online.com/brochure/plasma-derivatives-albumin-inj/r0th_S.jpg)
Brochure [Plasma derivatives] Albumin inj.
▪A 20% solution of human albumin prepared with a cold ethanol fractionation method from plasma from healthy donors -
![[Plasma derivatives] Green-VIII inj.](https://www.cphi-online.com/company/gc-biopharma/c308253th_S.jpg)
Brochure [Plasma derivatives] Green-VIII inj.
▪High concentrate of human anti-haemophilic factor VIII prepared from pooled plasma of healthy donors -
Brochure [Vaccine] BARYCELA inj.
▪Live attenuated varicella vaccine
- WHO-prequalified
- World's 1st Antibiotic-free varicella vaccine
-
Brochure [Vaccine] GCFLU inj.
▪Seasonal influenza vaccine
- WHO-prequalified
- Largest flu vaccine supplier to PAHO & UNICEF
-
Brochure [Rare disease] Hunterase IV
▪World's 2nd ERT for MPS II -
Brochure [Rare disease] Hunterase ICV
▪World's 1st ERT for Neuronopathic MPS II
-
Brochure Poster presentation of Varicella Vaccine in Kyoto
Assessment of Immunogenicity and Safety of the Live Attenuated Varicella Vaccine (BARYCELA) in Adolescents and Adults was presented in 19th Vaccine Congress -
Brochure GC Biopharma at the 2025 ICIEM in Kyoto
GCBP Hunterase L.I.N.K. Day of the year. Doctors from Paraguay, Chile, Peru, Russia, Algeria, Malaysia, and South Korea came together to share valuable insights -
Brochure Product List - GC Biopharma
Core Products of GC Biopharma -
Brochure Brochure of Green Cross
Brochure of Green Cross -
Brochure Company Presentation
GC Biopharma Company Presentation -
Brochure E-Catalog
E-Catalog of GC Biopharma -
Brochure Product List
Core product of GC Biopharma -
Brochure [CDMO] TOTAL SOLUTION for mRNA Medicines
GCBP offers a comprehensive, end-to-end mRNA CDMO service — covering codon-optimized sequence design, pDNA production, IVT mRNA synthesis, LNP formulation, aseptic fill & finish, and full analytical & regulatory support. With proprietary technologies and flexible manufacturing infrastructure, we enable fast and reliable development of mRNA vaccines and therapeutics.
-
![[Plasma derivatives] Alyglo](https://www.cphi-online.com/brochure/plasma-derivatives-alyglo/r157722th_S22893582.jpg)
Brochure [Plasma derivatives] Alyglo
FDA approved, Immune globuline Intravenous, 10% liquidPure Ig with extra purification step
-
![[Plasma Derivatives] Sero - Tet](https://www.cphi-online.com/brochure/plasma-derivatives-sero-tet/r157721th_S22663199.jpg)
Brochure [Plasma Derivatives] Sero - Tet
A sterile solution of tetanus immune globulin prepared from pooled plasma of healthy donors who have immunized against tetanus and a transparent solution of colorless -
Brochure [Plasma Derivatives] Hepabig
A sterile solution of hepatitis B immune globulin prepared by cold ethanol fractionation method, which had high titer of antibody to hepatitis B surface antigen and found negative for HBsAg, anti-HIV and anti-HCV